- Home
- PHUN vs SRZN Comparison
PHUN vs SRZN Comparison
Compare PHUN & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- SRZN
- Stock Information
- Founded
- PHUN 2009
- SRZN 2015
- Country
- PHUN United States
- SRZN United States
- Employees
- PHUN N/A
- SRZN N/A
- Industry
- PHUN EDP Services
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- PHUN Technology
- SRZN Health Care
- Exchange
- PHUN Nasdaq
- SRZN Nasdaq
- Market Cap
- PHUN 64.1M
- SRZN 72.8M
- IPO Year
- PHUN N/A
- SRZN N/A
- Fundamental
- Price
- PHUN $3.29
- SRZN $8.71
- Analyst Decision
- PHUN Buy
- SRZN Strong Buy
- Analyst Count
- PHUN 2
- SRZN 2
- Target Price
- PHUN $7.75
- SRZN $38.50
- AVG Volume (30 Days)
- PHUN 280.4K
- SRZN 22.6K
- Earning Date
- PHUN 08-07-2025
- SRZN 08-11-2025
- Dividend Yield
- PHUN N/A
- SRZN N/A
- EPS Growth
- PHUN N/A
- SRZN N/A
- EPS
- PHUN N/A
- SRZN N/A
- Revenue
- PHUN $2,956,000.00
- SRZN $11,638,000.00
- Revenue This Year
- PHUN $3.01
- SRZN N/A
- Revenue Next Year
- PHUN $50.72
- SRZN N/A
- P/E Ratio
- PHUN N/A
- SRZN N/A
- Revenue Growth
- PHUN N/A
- SRZN N/A
- 52 Week Low
- PHUN $2.22
- SRZN $5.90
- 52 Week High
- PHUN $14.60
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- PHUN 52.92
- SRZN 47.45
- Support Level
- PHUN $3.25
- SRZN $8.00
- Resistance Level
- PHUN $3.56
- SRZN $8.94
- Average True Range (ATR)
- PHUN 0.18
- SRZN 0.72
- MACD
- PHUN 0.01
- SRZN -0.07
- Stochastic Oscillator
- PHUN 61.97
- SRZN 27.14
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).